NXGL NexGel, Inc
$4.26▲ +7.45%
Healthcare
Other
After hours
$4.46▲ +4.82%
Oct 27, 5:48 PM ET
Volume 53.9K
Avg Volume (10D) 390.3K
Key Metrics & Fundamentals
Market Cap
$2.07M
P/E Ratio
–
Div Yield
0.00%
52W Range
3.00 - 53.60
% vs 50 MA
-20.92%
% vs 200 MA
-67.21%
RSI-14
44.7
MACD Histogram
+0.0700
Beta (1Y vs SPY)
0.15
Free Cash Flow
-$8.78M
Gross Rev
$3.69M
Gross Profit
$1.11M
EBITDA
-$2.96M
COGS
$2.58M
Operating Exp
$3.61M
Operating Income
-$2.51M
EBIT
-$2.51M
Pretax Income
-$3.61M
Net Income
-$3.64M
EPS (Diluted)
-0.40
Price & Volume History
Loading chart…
Recent News
NEXGEL Regains Compliance with Nasdaq Listing Requirement
GlobeNewswire · Oct 27, 2026 8:30 AM ET
NEXGEL Announces 1-for-20 Reverse Stock Split Effectiveness
GlobeNewswire · Oct 12, 2026 8:30 AM ET
NEXGEL Announces Dial-In Details for Investor Update Call
GlobeNewswire · Sep 23, 2026 9:29 AM ET
NEXGEL Announces Date for Investor Update Call
GlobeNewswire · Sep 16, 2026 9:29 AM ET
NEXGEL ANNOUNCES LEADERSHIP TRANSITION AND STRATEGIC REVIEW INITIATIVE
GlobeNewswire · Aug 20, 2026 4:05 PM ET
NEXGEL Q2 Revenue Reaches $3.69 Million as BioNX Integration Faces Slower Ramp
InvestorsHub · Aug 17, 2026 10:54 AM ET
NEXGEL Reports Second Quarter 2026 Financial Results
GlobeNewswire · Aug 17, 2026 8:00 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See NXGL's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.